Altogether, this study revealed a novel mechanism driving the chemoresistance of NSCLC cells that involves overexpression of TSN promoting targeted upregulation of S100A11 expression, which leads to PLA2 inhibition and the suppression of ROS-dependent apoptotic signaling, particularly in response to platinum-based chemotherapeutic treatment. This evidence concerns the gene TSN and non-small cell lung carcinoma.